Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Cost of Revenue: 2009-2020

Historic Cost of Revenue for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2020 value amounting to $5.7 million.

  • Avadel Pharmaceuticals' Cost of Revenue fell 9.30% to $3.3 million in Q2 2020 from the same period last year, while for Jun 2020 it was $11.0 million, marking a year-over-year decrease of 23.22%. This contributed to the annual value of $5.7 million for FY2020, which is 52.64% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Cost of Revenue of $5.7 million as of FY2020, which was down 52.64% from $12.1 million recorded in FY2019.
  • Avadel Pharmaceuticals' 5-year Cost of Revenue high stood at $17.5 million for FY2018, and its period low was $5.7 million during FY2020.
  • For the 3-year period, Avadel Pharmaceuticals' Cost of Revenue averaged around $11.8 million, with its median value being $12.1 million (2019).
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Cost of Revenue climbed by 23.04% in 2017, and later slumped by 52.64% in 2020.
  • Avadel Pharmaceuticals' Cost of Revenue (Yearly) stood at $13.2 million in 2016, then climbed by 23.04% to $16.3 million in 2017, then climbed by 7.45% to $17.5 million in 2018, then tumbled by 30.78% to $12.1 million in 2019, then slumped by 52.64% to $5.7 million in 2020.